Tennis champion Novak Djokovic holds an 80% stake in Danish biotech agency Quantbiorace, which goals to develop a medical remedy to fight COVID-19, the corporate’s chief government instructed Reuters on Wednesday.
CEO Ivan Lonkarevich, who describes himself as an entrepreneur, stated the funding was made in June 2020, however declined to say how a lot.
According to Lonkarevi, Quantbiores has about 11 researchers working in Denmark, Australia and Slovenia, who insisted they have been engaged on a remedy, not a vaccine.
He stated the corporate creating a peptide that stops the coronavirus from infecting a human cell is predicted to start scientific trials within the UK this summer season.
Djokovic’s spokesman didn’t instantly reply to a request for remark.
Tennis primary has sparked a world debate concerning the rights of those that select to not be vaccinated after being pulled out of Australia on Sunday evening, ruling them out of the Australian Open.
,
With inputs from TheIndianEXPRESS
